GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Nov 16, 2015

Total Value ($000): $252,823 (100.0% shares, 0.0% debt)

Holdings (36)

VNDA VANDA PHARMACEUTICALS INC 7.7%
Value ($000) $19,345 Shares 1,715,000 Est. Cost $11.46 Unrealized +6.8%
FIVE PRIME THERAPEUTICS INC 7.5%
Value ($000) $18,880 Shares 1,226,785 Est. Cost $20.62 Unrealized
CONNECTURE INC 7.4%
Value ($000) $18,820 Shares 4,127,232 Est. Cost $9.01 Unrealized
ADAMAS PHARMACEUTICALS INC 7.3%
Value ($000) $18,581 Shares 1,110,000 Est. Cost $18.53 Unrealized
ZOGENIX INC 7.3%
Value ($000) $18,397 Shares 1,362,763 Est. Cost $13.50 Unrealized
DYAX CORP 5.7%
Value ($000) $14,318 Shares 750,000 Est. Cost $20.69 Unrealized
RELYPSA INC 5.6%
Value ($000) $14,235 Shares 769,047 Est. Cost $23.06 Unrealized
GW PHARMACEUTICALS PLC 3.8%
Value ($000) $9,484 Shares 103,800 Est. Cost Unrealized
GW PHARMACEUTICALS PLC 3.6%
Value ($000) $9,137 Shares 100,000 Est. Cost Unrealized
EXEL EXELIXIS, INC 3.5%
Value ($000) $8,920 Shares 1,590,000 Est. Cost $5.44 Unrealized 0.0%
PARATEK PHARMACEUTICALS INC 3.4%
Value ($000) $8,624 Shares 453,878 Est. Cost $25.19 Unrealized
TETRAPHASE PHARMACEUTICALS I 3.3%
Value ($000) $8,355 Shares 1,120,000 Est. Cost $7.46 Unrealized
RAPTOR PHARMACEUTICAL CORP 3.2%
Value ($000) $8,077 Shares 1,335,000 Est. Cost $6.05 Unrealized
ALCOBRA LTD 2.9%
Value ($000) $7,279 Shares 1,205,183 Est. Cost $5.79 Unrealized
ARADIGM CORP 2.9%
Value ($000) $7,221 Shares 1,002,962 Est. Cost $8.85 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 2.7%
Value ($000) $6,917 Shares 2,457,144 Est. Cost $3.52 Unrealized -2.8%
OCERA THERAPEUTICS INC 2.5%
Value ($000) $6,206 Shares 1,963,777 Est. Cost $6.20 Unrealized
SYNERGY PHARMACEUTICALS DEL 2.4%
Value ($000) $6,019 Shares 1,135,580 Est. Cost $8.30 Unrealized
MEDICINES CO 2.3%
Value ($000) $5,694 Shares 150,000 Est. Cost $37.96 Unrealized
VCEL VERICEL CORP 2.2%
Value ($000) $5,653 Shares 2,086,028 Est. Cost $2.85 Unrealized +15.4%
BOVIE MEDICAL CORP 2.1%
Value ($000) $5,226 Shares 2,680,000 Est. Cost $2.72 Unrealized
STEMLINE THERAPEUTICS INC 1.7%
Value ($000) $4,196 Shares 475,200 Est. Cost $14.47 Unrealized
ALIMERA SCIENCES INC 1.5%
Value ($000) $3,720 Shares 1,683,162 Est. Cost $6.86 Unrealized
CALADRIUS BIOSCIENCES INC 1.3%
Value ($000) $3,351 Shares 2,248,781 Est. Cost $1.87 Unrealized
TENAX THERAPEUTICS INC 1.3%
Value ($000) $3,326 Shares 1,108,593 Est. Cost $3.93 Unrealized
SUNESIS PHARMACEUTICALS INC 1.0%
Value ($000) $2,633 Shares 3,250,000 Est. Cost $2.35 Unrealized
ANTARES PHARMA INC 0.7%
Value ($000) $1,732 Shares 1,018,627 Est. Cost $2.08 Unrealized
BIODEL INC 0.6%
Value ($000) $1,459 Shares 3,316,966 Est. Cost $1.03 Unrealized
AQUINOX PHARMACEUTICALS INC 0.6%
Value ($000) $1,407 Shares 100,000 Est. Cost $14.07 Unrealized
OSIRIS THERAPEUTICS INC NEW 0.5%
Value ($000) $1,385 Shares 75,000 Est. Cost $18.47 Unrealized
FLEXION THERAPEUTICS INC 0.4%
Value ($000) $985 Shares 66,300 Est. Cost Unrealized
THRESHOLD PHARMACEUTICALS INC 0.3%
Value ($000) $858 Shares 210,800 Est. Cost Unrealized
TRANSITION THERAPEUTICS INC 0.3%
Value ($000) $800 Shares 447,026 Est. Cost $1.79 Unrealized
DISCOVERY LABORATORIES INC N 0.3%
Value ($000) $759 Shares 2,530,532 Est. Cost $0.30 Unrealized
DERMA SCIENCES INC CMN 0.2%
Value ($000) $477 Shares 101,235 Est. Cost $12.35 Unrealized
STREAMLINE HEALTH SOLUTIONS 0.1%
Value ($000) $347 Shares 151,611 Est. Cost $6.45 Unrealized